Entries |
Document | Title | Date |
20080206358 | Pharmaceutically Active Compounds, their Manufacture, Compositions Containing them, and their Use - A substance for use as a medicament, comprises a solid mixed metal compound of formula (I): M | 08-28-2008 |
20080241273 | MASTIC GUM COMPOSITION FOR USE AS A DIETARY SUPPLEMENT IN HUMANS AND ANIMALS - A dietary supplement and herbal formula and treatment methodology for humans and animals, having as its primary ingredient mastic gum extract, for the support, increase and production, function, and/or treatment of the kidneys. | 10-02-2008 |
20080260861 | Modulating Lymphatic Function - Methods and compositions for modulating lymphatic function, e.g., by altering NO levels, are disclosed. | 10-23-2008 |
20080305184 | Pigment Mixture - The invention relates to a pigment mixture consisting of at least two constituents, constituent A being uncoated, monocoated or multicoated glass lamellae, and constituent B being nacreous pigments based on phyllosilicates, SiO | 12-11-2008 |
20090017137 | Methods and compositions for the prevention and treatment of anemia - Methods for increasing and maintaining hematocrit in a mammal comprising administering a hyperglycosylated analog of erythropoietin are disclosed. An analog may be administered less frequently than an equivalent molar amount of recombinant human erythropoietin to obtain a comparable target hematocrit and treat anemia. Alternatively, a lower molar amount of a hyperglycosylated analog may be administered to obtain a comparable target hematocrit and treat anemia. Also disclosed are new hyperglycosylated erythropoietin analogs, methods of production of the analogs, and compositions comprising the analogs. | 01-15-2009 |
20090028962 | Methods and Compositions for Enhancing Iron Absorption - The present invention generally relates to methods and compositions useful in enhancing iron absorption in a patient. The methods and compositions of the present invention may be used independently to promote and/or maintain iron absorption in a patient or may be used in combination with one or more other compositions used in the treatment of one or more diseases having iron deficiency associated therewith. | 01-29-2009 |
20090081315 | IRON COMPOSITION CONTAINING MILK PROTEIN - There are provided an iron composition including a milk protein and an iron preparation, which is stable in the presence of a substance having a property of releasing iron from the composition or reducing the released iron, and foods or drinks, animal feeds, and medicines blended with the iron composition. A milk protein such as skim milk is blended into an iron preparation, thereby producing the iron composition which is stable in the presence of a substance having a property of releasing iron from the composition or reducing the released iron (e.g., vitamin C or citric acid). | 03-26-2009 |
20090123565 | Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto - The present invention relates to the discovery that non-traditional export of certain pro-inflammatory cytokines lacking a signal sequence from a cell can be inhibited by copper chelation and/or administration to the cell of a truncated form of S100A13 lacking the basic residue portion. Further, copper chelation inhibits, inter alia, neointima formation, macrophage infiltration and associated inflammation, cell proliferation, secretion of extracellular matrix, intimal thickening, adventitial angiogenesis, restenosis, and the like, associated with vascular vessel injury. Thus, the present invention provides novel methods of preventing and treating, and for identifying novel compounds also useful as therapeutics for, such conditions. | 05-14-2009 |
20090123566 | USE OF A PHOSPHATE ADSORBENT TO COMBAT VASCULAR DISEASES - The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and preventing atherosclerotic vascular diseases or/and disturbances of bone metabolism. | 05-14-2009 |
20090130227 | EXTERNAL PREPARATION FOR SKIN - The present invention provides an external preparation for skin which contains 5-aminolevulinic acids as active components and which is excellent in skin-beautifying effects such as prevention/amelioration of skin roughness, dry skin, wrinkles, sagging and flecks of skin, and improvement of turnover of corneum; and in an ameliorating effect on skin diseases such as atopic dermatitis. An external preparation for skin which contains one or more compounds selected from the group consisting of 5-aminolevulinic acid, its salt and a derivative of them; and an iron compound; as active components, is used. | 05-21-2009 |
20090136593 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY - The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms. | 05-28-2009 |
20090169645 | Iron Sulfate-Based Phosphate Adsorbent - The present invention relates to a process for the preparation of a novel composition, and to the use of the composition as a phosphate adsorbent, in particular for administration in humans or animals. | 07-02-2009 |
20090238895 | NUTRITIONAL AND/OR PHARMACEUTICAL PREPARATION FOR USE IN PROPHYLAXIS AND TREATMENT OF DISTURBANCES IN MICROELEMENTS ABSORPTION FROM THE ALIMENTARY CANAL - The invention dissolves the problem of the pharmaceutical preparation being a factor stimulating the absorption of microelements. The essence of the invention is that the preparation contains alpha-keto-glutarate or/and glutamine or/and glutamate or/and ornithine of alpha-keto-glutarate, dipeptide of glutamine and other amino acids or/and tripeptides of glutamine and other amino acids or/and glutamate with other amino acid or/and salts of alpha-keto-glutarate or/and glutamine or/and glutamate or/and ornithine of alpha-keto-glutarate, dipepetides of glutamine or glutamate with other amino acid in a dose 0.01-0.5 g/kg/day and administered orally stimulates the absorption of iron, zinc, copper, manganese, strontium, calcium, phosphorus and other microelements from the alimentary canal to the blood ensuring proper—physiological—curative level of these compounds in the blood of people and animals. | 09-24-2009 |
20090246294 | PIGMENT MIXTURE, AND USE THEREOF IN COSMETICS, FOOD AND PHARMACEUTICALS - The invention relates to pigment mixtures comprising at least two components A and B. The inventive pigment mixtures are characterized in that component A is embodied as effect pigments while component B is embodied as coloring agents and fillers. Also disclosed is the use of said pigment mixtures in cosmetic formulations and for coloring food products and pharmaceutical products. | 10-01-2009 |
20090258088 | USE OF MATERIALS AND EXTERNAL STIMULI FOR SYNOVECTOMY - This invention has as one of its aspects a method to provide a safe an effective treatment for synovectomy. The method involves the administration a material to the affected joint, allowing the material to localize in the synovial membrane, and then applying an external stimulus that interacts with the material to provide therapy. The materials of this invention are preferably particles, which are either magnetic or contain a heavy element. The external stimuli of this invention includes an alternating magnetic field to heat magnetic particles, infrared laser to heat heavy elements, or electromagnetic ionizing radiation (X- or gamma-radiation) that interacts with heavy elements to produce a localized radiation dose. | 10-15-2009 |
20090269420 | SUBSTITUTED DIHYDROPYRAZOLONES AND THEIR USE - The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and haematological diseases and kidney diseases, and for promoting wound healing. | 10-29-2009 |
20090304815 | METHOD OF TREATMENT FOR MUSCULAR DYSTROPHY - The invention relates to a method of treatment for muscular dystrophies, including Duchenne, Becker, limb-girdle, facioscapulohumeral, congenital muscular dystrophies and the like using a combination of nitric oxide-releasing and anti-inflammatory compounds. | 12-10-2009 |
20100021564 | OM VITAMIN FORMULA - I have invented a vitamin formula named as “OM VITAMIN FORMULA” that will alleviate the ill-health symptoms induced by Lead intoxication from tap water or by some other means. Ill-health symptoms are: pain, itching, burning, insomnia, depression, panic attacks, infections, elevated blood pressure, elevated cholesterol . . . . Also likely blood sugar level will be elevated. Lack of vitamins in presence of Lead in body will affect body growth and other body functions. As Lead increases the requirements of vitamins in body so body cells start becoming mega (bloated) and will result in obesity. | 01-28-2010 |
20100021565 | Pearlescent Pigments - The present invention relates to pearlescent pigments based on flake-form substrates which have at least one FeOOH layer and at least one TiO | 01-28-2010 |
20100068301 | COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS - Disclosed herein are compositions and compounds that combine an inhibitor of | 03-18-2010 |
20100074968 | AGENT AND METHOD FOR TREATING CANCER COMPRISING STRONTIUM, AMINO ACID(S) AND MINERAL AGENT(S) - The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method for treatment and prophylaxis of cancer. | 03-25-2010 |
20100119619 | AQUEOUS GEL HAVING AN ALPHA-HYDROXY ACID AND SUSPENDED PARTICULATES - A personal care composition in the form of an aqueous gel may comprise an alpha-hydroxy acid, wherein the pH of the composition is less than about 4.5. The personal care composition comprises a gelling agent and an aqueous solvent. The personal care composition further comprises particulates and an effective amount of suspension agent to suspend the particulates. The personal care composition exhibits a consumer desired viscosity and translucency. | 05-13-2010 |
20100151049 | MATERIALS AND METHODS FOR PREPARATION OF ALKALINE EARTH FERRATES FROM ALKALINE EARTH OXIDES, PEROXIDES, AND NITRATES - The subject invention concerns methods for preparing alkaline earth ferrates and the preparation of hemostatic compositions from alkaline earth ferrates. In one embodiment, the alkaline earth ferrate is strontium ferrate. In one embodiment, methods of the invention comprise heat treating mixtures of alkaline earth oxides and/or peroxides with iron oxides, such as hematite or magnetite. The subject invention also concerns hemostatic compositions produced using metallic oxides that are reacted with alkaline earth oxides and/or peroxides and the methods used to produce the hemostatic compositions. | 06-17-2010 |
20100178361 | METHOD OF STABILIZING IRON COMPOSITIONS WITH MILK PROTEIN - There are provided an iron composition including a milk protein and an iron preparation, which is stable in the presence of a substance having a property of releasing iron from the composition or reducing the released iron, and foods or drinks, animal feeds, and medicines blended with the iron composition. A milk protein such as skim milk is blended into an iron preparation, thereby producing the iron composition which is stable in the presence of a substance having a property of releasing iron from the composition or reducing the released iron (e.g., vitamin C or citric acid). | 07-15-2010 |
20100215770 | MIXED METAL COMPOUNDS FOR TREATMENT OF HYPERPHOSPHATAEMIA - The present invention relates to mixed metal compounds having pharmaceutical activity, especially as phosphate binders. It also extends to methods of manufacture of those compounds, as well as to pharmaceutical compositions containing such compounds. It further relates to their pharmaceutical use. In particular, the present invention relates to use of compounds of Formula (I): M | 08-26-2010 |
20100278941 | Enhanced erythropoiesis and iron metabolism - The present invention relates to methods and compounds for regulating or enhancing erthropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease. | 11-04-2010 |
20100297261 | Food Product and Fortification System Therefor - A food product comprising a source of at least one metal ion selected from Fe and Cu ions and an ascorbic acid derivative substituted in the 2-position, wherein the molar ratio of the metal ion or metal ions in the source of metal ions to the ascorbic acid derivative is from 1:0.5 to 1:15. | 11-25-2010 |
20100316734 | METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT - Methods and systems for treatment based on thermographic images of a patient to detect temperature patterns indicative of an evolving disease process. Guided by the thermographic image obtained, a treatment means can be positioned on the skin of the imaged body part. The treatment means comprises a medicament that reduces risk factor(s) associated with the progression of the evolving disease process. | 12-16-2010 |
20110003012 | TREATING PATIENTS WITH SUBARACHNOID HEMORRHAGE - A method for attenuating vasoconstriction in a patient with subarachnoid hemorrhage by administering to the patient a therapeutically effective amount of a compound which mediates an increase of bioactive nitric oxide in blood or tissue in the subarachnoid space to cause vasodilation in cerebral, carotid and basilar arteries after the administration of the compound, and wherein the administration of the compound does not reduce mean arterial blood pressure by more than 10%. | 01-06-2011 |
20110003013 | METHOD OF INCREASING METABOLISM - The present invention provides a method for increasing metabolism and/or energy expenditure in a subject, e.g., to treat or prevent obesity and/or a related condition and/or to reduce adiposity, the method comprising increasing the level and/or activity of Hypoxia Induced Factor 1α (HIF-1α) in a cell, tissue or organ of the subject, thereby increasing metabolism in the subject. The present invention also provides a method for increasing metabolism in a subject, the method comprising administering an iron chelating agent to the subject, thereby increasing metabolism in the subject. | 01-06-2011 |
20110008464 | METHODS AND COMPOSITIONS FOR TREATING THYROID-RELATED MEDICAL CONDITIONS WITH REDUCED FOLATES - The present invention provides methods and compositions for treating thyroid-related medical conditions. Many thyroid-related medical conditions exist that go undiagnosed and untreated. These conditions may be prevented and treated with reduced folates and vitamin B12. Administration of reduced folates and vitamin B12 will prevent or treat cerebrospinal folate deficiency, which is linked to thyroid-related medical conditions. Administration of reduced folates and vitamin B12 will also prevent or treat conditions associated with masked megaloblastic anemia and hypothyroidism, and other conditions brought upon through improper thyroid function. Additionally, it is commonplace to treat many thyroid conditions with anti-thyroid drugs or thyroid stimulating drugs. This practice alone is also responsible for causing, or not beneficially addressing, adverse conditions that can be prevented or treated through the methods and compositions discussed herein. | 01-13-2011 |
20110027388 | Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola Virus - Hexaamminecobalt(III) chloride, also called Cohex, reduces the extent of viral infection, including difficult to treat infections caused by Ebola virus and HIV. Disclosed are methods for treating a viral infection, comprising administering to a patient a cobalt(III) hexammine compound in an amount effective to reduce an extent of a viral infection. Also disclosed are kits for delivery of a cobalt(III) hexammine compound by injection. | 02-03-2011 |
20110038950 | Enhanced erythropoiesis and iron metabolism - The present invention relates to methods and compounds for regulating or enhancing erythropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease. | 02-17-2011 |
20110081424 | NUTRITIONAL COMPOSITION FOR BARIATRIC SURGERY PATIENTS - A ready-to-consume liquid nutritional composition which is particularly suitable for use by morbidly obese patients pre- and post-bariatric surgery. The composition comprises an energy content between 80-160 kcal/100 ml, a protein content between 40-80 En %, a digestible carbohydrate content between 0-30 En %, a fat content between 5-40 En %, a soluble dietary fibre content between 1.5-8 g/100 kcal, and micronutrients. The micronutrients comprise calcium in an amount between 150-1000 mg/100 kcal, phosphorus in an amount between 100-1000 mg/100 kcal, with a Ca:P ratio of at least 1.0, iron in an amount between 4-50 mg/100 kcal, vitamin D in an amount between 2-400 mcg/100 kcal and vitamin B12 in an amount between 0.5-300 mcg/100 kcal. | 04-07-2011 |
20110135754 | CONTROL OF DISEASES IN CROPS - A composition and a method for controlling a fungal disease, such as rust, in a crop, such as a grain crop, where said composition contains a vanadium containing compound that can be applied to the seed, or to the crop, or to the ground before, during or after seeding. | 06-09-2011 |
20110142959 | METHODS, SYSTEMS AND COMPOSITIONS INVOLVED IN THE SYNTHESIS OF NONSTABLE COMPOUNDS - Systems, compositions, and methods for producing one or more unstable chemical species uniformly at an invariant rate of production over time and at substantially precise and/or exact concentrations are disclosed. The produced unstable product is synthesized from unstable chemical reactants. The present disclosure further describes methods of storage of an unstable chemical product to deliver it at a specific desired concentration at a specific time. | 06-16-2011 |
20110177172 | MONO (IRON HYDROXYPYRONE) AND COMBINATION (IRON HYDROXYPYRONE AND GI INFLAMMATION INHIBITING AGENTS) COMPOSITIONS FOR ANAEMIA OR H. PYLORI INFECTIONS - There is provided a composition or kit of parts comprising: one or more compounds capable of treating and/or preventing an inflammatory disease of the gastrointestinal tract: and an iron hydroxypyrone, for increasing the level of iron in a patient's bloodstream and/or treating and/or preventing anaemia such as iron deficiency anaemia. A composition comprising iron hydroxypyrone is also provided for administration to a subject: having or at risk of having achlorhydria; wherein the gastric pH of the subject is equal to or greater than about 4; or wherein the subject has an inflammatory disease of the gastrointestinal tract. | 07-21-2011 |
20110262560 | Pigmented Emulsion Makeup Compositions With Gemstones - A pigmented emulsion composition comprising a water phase, an oil phase, and a plurality of gemstones in particulate form, and a method for providing a glow to the skin and ameliorating the appearance of wrinkles, lines, and skin discoloration by applying a pigmented emulsion composition comprising a plurality of gemstones. | 10-27-2011 |
20110268818 | NGAL-BINDING SIDEROPHORES AND USE THEREOF TO TREAT IRON DEFICIENCY AND IRON OVERLOAD - The invention provides compositions comprising a lipocalin, such as NGAL, and a mammalian siderophore that are useful as iron chelators and iron donors. The invention also provides mammalian siderophore compounds of Formula (I): The invention further provides, methods of treatment and methods of diagnosis. | 11-03-2011 |
20110311650 | MULTIPLEXED BIOMARKERS OF INSULIN RESISTANCE - The invention, in some aspects, relates to methods for characterizing glucose-related metabolic disorders. In some aspects, the invention relates to methods and kits useful for diagnosing, classifying, profiling, and treating glucose-related metabolic disorders. In some aspects, the invention relates to methods useful for diagnosing, classifying, profiling, and treating diabetes. | 12-22-2011 |
20120121727 | SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGICAL DISEASES - The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing. | 05-17-2012 |
20120195976 | METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION - The present invention relates to the treatment of disorders using heme oxygenase-1 and heme degradation products. | 08-02-2012 |
20120207854 | METAL POLYSULFIDE-COMPLEX WITH BIOLOGICAL AND CHEMICAL ACTIVITY - Aqueous solution, cream, hydrogel or spray composition containing compound Sn-On-Xn; where S(n=5-8), O (n=3-7) and X═Fe, Cr or Ni, and most effectively, S7-O4-Fe4 as active ingredient for cutaneous, intradermal and subcutaneous treatment of dermo-epithelial lesions, comprising but not limited to, certain types of skin cancer (basal cell, keratocanthoma and spinocellular carcinomas), conjunctivitis, folliculitis, acne, gingivitis, stomatitis, fungal, dermatomycosis, parasitosis, condylomatosis, balanitis, vaginitis, vaginosis, bacteriosis and endometriosis; by reducing the number of infecting microorganism, not limited to | 08-16-2012 |
20120213866 | METHOD AND SYSTEM FOR MODULATING SUBSTANCES AFFECTING BODILY PROCESSES - A method for establishing a treatment for promoting the formation of substances in an individual. The measured or assessed level of substances in the body are compared in order to determine the treatment to provide to an individual. | 08-23-2012 |
20120251629 | METHODS OF TREATMENT AND SCREENING ASSAYS FOR HIF-1ALPHA REGULATION - The present invention relates to a method of treating a patient for a condition where blood flow to a tissue or organ is interrupted. This method involves administering to a patient with a hypoxic condition where blood flow to a tissue or organ is interrupted, or at risk thereof, a compound that reduces the rate of HIF-1α inactivation in cells affected by the condition, thereby treating the patient for the condition. Also disclosed is a method of treating a tumor in a patient. In addition, the present invention relates to methods of identifying compounds as candidate drugs for treatment of hypoxic conditions and for treating tumors in a subject. | 10-04-2012 |
20120269900 | COMPOSITIONS AND METHODS FOR A BUG REPELLENT - The present invention relates to compositions and methods for deterring and repelling all types of organisms capable of sensing electric or magnetic fields, including insects and arachnids. The compositions contain electrically or magnetically imprintable substances comprising an electric or magnetic charge or imprint, wherein the imprint contains the signature of at least one target organism; and an acceptable carrier. | 10-25-2012 |
20120308668 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY - The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms. | 12-06-2012 |
20130064900 | Anti-dandruff methods, processes and compositions - New methods, compositions, and processes for the treatment of symptoms of dandruff using cellular adhesion modulators are disclosed. | 03-14-2013 |
20130089623 | Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates - The present invention provides methods and compositions for treating thyroid-related medical conditions. Many thyroid-related medical conditions exist that go undiagnosed and untreated. These conditions may be prevented and treated with reduced folates and vitamin B12. Administration of reduced folates and vitamin B12 will prevent or treat cerebrospinal folate deficiency, which is linked to thyroid-related medical conditions. Administration of reduced folates and vitamin B12 will also prevent or treat conditions associated with masked megaloblastic anemia and hypothyroidism, and other conditions brought upon through improper thyroid function. Additionally, it is commonplace to treat many thyroid conditions with anti-thyroid drugs or thyroid stimulating drugs. This practice alone is also responsible for causing, or not beneficially addressing, adverse conditions that can be prevented or treated through the methods and compositions discussed herein. | 04-11-2013 |
20130108709 | TREATMENT OF MITOCHONDRIA-RELATED DISEASES AND IMPROVEMENT OF AGE-RELATED METABOLIC DEFICITS | 05-02-2013 |
20130177659 | Therapeutic Use of Tetrathiomolybdate - Tetrathiomolybdate is for use in therapy of a condition requiring reduced metabolism of an organ or whole body, e.g. myocardial infection, stroke or ischaemia-reperfusion injury. | 07-11-2013 |
20130189374 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION - The present invention generally relates to methods and compositions useful in enhancing iron absorption in a patient. The methods and compositions of the present invention may be used independently to promote and/or maintain iron absorption in a patient or may be used in combination with one or more other compositions used in the treatment of one or more diseases having iron deficiency associated therewith. | 07-25-2013 |
20130236566 | Red Blood Cell Dynamics for Diagnosis - Methods for identifying patients with anemia, distinguishing thalassemia-trait anemia from iron-deficiency anemia, and identifying pre-anemic patients several weeks before anemia becomes clinically detectable. Also, methods for detecting blood doping in athletes and for optimizing therapy with erythropoiesis stimulating agents or iron supplementation. Computer-readable storage devices and systems, e.g., for use in the described methods. | 09-12-2013 |
20130287864 | METHOD FOR PRODUCING BIOACTIVE AGENT, BIOACTIVE AGENT PRODUCED THEREBY, COSMETIC, FRESHNESS-MAINTAINING AGENT, GROWTH PROMOTION AGENT, SOIL CONDITIONING AGENT, AND PHARMACEUTICAL STOCK SOLUTION - The object of the invention is to provide a bioactive agent in which the bioactive effectiveness of ferric iron salt and/or ferric ferrous iron salt contained therein is stabilized, making long term preservation possible, so that the bioactive agent can be useful as an original solution for medical use, as a soil conditioner, or the like. An iron-magnesium mixture solution is provided in the invention, wherein the iron-magnesium mixture solution is produced by mixing an aqueous solution containing a ferric iron salt and/or a ferric ferrous iron salt in a concentration of not less than 0.5 mol/L as iron in the ferric iron salt and/or the ferric ferrous iron salt, and an aqueous solution containing a magnesium salt in a concentration of not less than 0.2 mol/L as magnesium in the magnesium salt. | 10-31-2013 |
20130295196 | LAUFLUMIDE AND THE ENANTIOMERS THEREOF, METHOD FOR PREPARING SAME AND THERAPEUTIC USES THEREOF - The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or idiopathic hypersomnia. | 11-07-2013 |
20130309322 | COMPOSITIONS FOR IMPROVING MENTAL PERFORMANCE - The present invention provides formulas for producing compositions for the structural/functional nutritional support for those who struggle with poor focus, concentration and/or memory. In addition, the present invention provides compositions comprising nutritional/botanical factors helpful to those who subjectively experience transient mental fatigue or poor cognitive function. The compositions of this invention consist primarily of the following ingredients B-complex vitamins, antioxidants, minerals, phosphatidyl serine (PS), choline, dimenthyl-aminoethanol (DMAE), docosahexaenoic acid (DHA), L-pyroglutamic acid, as well as herbal extracts from | 11-21-2013 |
20130323324 | VANADIUM AND VANADYL AMINO ACID COMPLEXES - Compositions that include vanadium or vanadyl chelated to an amino acid are disclosed, particularly vanadium or vanadyl chelated to creatine, arginine, citrulline, taurine, phenylalanine, glutamine, glutathione, leucine, or combinations thereof. In addition, compositions that included blended forms of such chelates and/or vanadyl sulfate and one or more unbound amino acids. Still further, the compositions disclosed may further include one or more additional proteins, amino acids, vitamins, minerals, or combinations thereof, which impart an additional nutritional and/or therapeutic benefit to the composition. | 12-05-2013 |
20140017339 | MATERIALS AND METHODS FOR TREATING RADIATION POISONING - Disclosed herein are materials and methods for treating patients that have been exposed to pathological levels on ionizing radiation. These materials and methods include administering to a patient in thereof at least one dose of a compound such as prostaglandin (PGE | 01-16-2014 |
20140030359 | Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates - The present invention provides methods and compositions for treating thyroid-related medical conditions. Many thyroid-related medical conditions exist that go undiagnosed and untreated. These conditions may be prevented and treated with reduced folates and vitamin B12. Administration of reduced folates and vitamin B12 will prevent or treat cerebrospinal folate deficiency, which is linked to thyroid-related medical conditions. Administration of reduced folates and vitamin B12 will also prevent or treat conditions associated with masked megaloblastic anemia and hypothyroidism, and other conditions brought upon through improper thyroid function. Additionally, it is commonplace to treat many thyroid conditions with anti-thyroid drugs or thyroid stimulating drugs. This practice alone is also responsible for causing, or not beneficially addressing, adverse conditions that can be prevented or treated through the methods and compositions discussed herein. | 01-30-2014 |
20140120180 | METAL COMPOUNDS MIXED OR SULPHATED, AS PHOSPHATE BINDERS - A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8. | 05-01-2014 |
20140127325 | Compositions and Method for Inhibiting Hepcidin Antimicrobial Peptide (HAMP) or HAMP-Related Gene Expression - The invention relates to lipid formulated double-stranded ribonucleic acid (dsRNA) targeting a hepcidin antimicrobial peptide (HAMP) and/or HAMP-related gene, and methods of using the dsRNA to inhibit expression of HAMP and/or HAMP-related genes. | 05-08-2014 |
20140141098 | USE OF INHALED GASEOUS NITRIC OXIDE AS A MUCOLYTIC AGENT OR EXPECTORANT - Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways. | 05-22-2014 |
20140178498 | METHOD FOR GENERATION OF NANOPARTICLES COMPOSITE FILMS AND FILMS MADE USING SUCH A METHOD - Proposed is a method for the production of at least one composite layer ( | 06-26-2014 |
20140186466 | NEUTRACEUTICAL FORMULATION FOR TREATMENT OF DIABETES - Disclosed are compositions of matter useful for the treatment of diabetes. In one embodiment a nutraceutical composition is administered to a patient in need, said composition comprising of one or more ingredients selected from a group consisting of: magnesium, chromium picolinate, alpha lipoic acid, | 07-03-2014 |
20140348949 | OM VITAMIN FORMULA - A composition comprising various vitamins to make a multi-vitamin. The vitamins identified in multi-vitamin include vitamin B-1, vitamin B-2, niacinamide, vitamin B-6, vitamin B-12, pantothenic acid, folic acid, beta carotene, iron, biotin, choline, vitamin A, vitamin E and vitamin C. The multi-vitamin soothe pain, depression, weakness and insomnia and works best with variety of food and less dairy products. Lead combined with calcium effects are severe than lead effects only; it elevates blood pressure, cholesterol, glucose, weight and cause frequent infections; bigger than normal dose of antibiotics need in infections; and variation in quantities of vitamins are needed to soothe the symptoms. | 11-27-2014 |
20140363520 | WET HAND TOWEL AND METHOD FOR PRODUCING THE SAME - A substrate contains a composition including VOSO | 12-11-2014 |
20150017261 | Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway - The present disclosure provides methods of treating and/or preventing cancer in a subject comprising administering to the subject a copper-reduced diet by itself or as a supplement along with a regular diet to create a copper-reduced melieu, maintain a reduced-copper melieu, or both, thereby treating and/or preventing the development of the cancer. Methods also comprise further adding a copper chelator, MEK inhibitor, or combinations thereof. | 01-15-2015 |
20150056299 | FOOD SUPPLEMENT TO SUPPORT BRAIN FUNCTION - The present invention relates to a food supplement to support brain function, including cognitive functions such as memory. The food supplement comprises one or more active ingredients selected from the group consisting of uridine, cytidine, glutamine, pantothenic acid, iron, colostrinin and caffeine. | 02-26-2015 |
20150306029 | GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION - Gummy dosage forms comprising gummy compositions for nutritional supplementation, methods for providing nutritional supplementation, and kits comprising gummy compositions for nutritional supplementation are disclosed. Such gummy compositions for nutritional supplementation may provide improved patient compliance relative to non-gummy compositions for nutritional supplementation. These gummy compositions can be used to administer one or more vitamins, minerals, or trace elements. | 10-29-2015 |
20150315250 | TRANSGENIC PLANTS WITH INCREASED TRACE ELEMENT CONTENTS AND METHODS FOR PRODUCING THE SAME - The present invention relates to a transgenic plant with increased trace element contents and a method for producing the same. In particular, the transgenic plant is incorporated by a polynucleotide encoding an iron-regulated protein 1 (IRP1/IMA1) or IRP1-like (IRL/IMA3) polypeptide, which facilitate uptake and circulation of the trace elements into the plant. Also provided is a method for treating trace element deficiency by administrating to a subject in need a composition comprising a transgenic plant as described or an edible tissue or part thereof. | 11-05-2015 |
20150374749 | COMBINATION OF NITROPRUSSIDE AND A SULFIDE SALT AS AN HNO-RELEASING THERAPEUTIC FOR THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES - The present invention relates to the combination of a nitroprusside salt or a solvate thereof with a sulfide salt or a solvate thereof for use in the treatment or prevention of a cardiovascular disease/disorder, such as heart failure, heart attack or hypertension. | 12-31-2015 |
20160008416 | FORMULATIONS FOR PREVENTING AND TREATING DECREASING PLATELET CELL COUNTS | 01-14-2016 |
20160022631 | Methods and Compositions for Enhancing Iron Absorption - The present invention generally relates to methods and compositions useful in enhancing iron absorption in a patient. The methods and compositions of the present invention may be used independently to promote and/or maintain iron absorption in a patient or may be used in combination with one or more other compositions used in the treatment of one or more diseases having iron deficiency associated therewith. | 01-28-2016 |
20160022733 | NOVEL FORMULA OF IRON BASED NANOCOMPOSITES FOR RAPID AND EFFICIENT TREATMENT OF IRON DEFICIENCY ANEMIA - New formulas of Iron oxides nanoparticles capped with a mixture of multivitamins such as folic acid, Nicotinic acid (vitamin B9) and Ascorbic acid (vitamin C) has been developed for the rapid and efficient treatment of life threatening iron-deficiency anemia. Small single dose of iron oxides-multivitamin nano-composite as low as 8.3 mg elemental iron per does is sufficient to increase the hemoglobin level from 4.4 g/dl up to 14.6 g/dl within only four days after administration. The multivitamin which used in this nano-composite enhances iron absorption significantly and elevated the concentration of hemoglobin. Two dosage forms of Iron nano-composites have been developed, gel capsules and aqueous solution for oral administration. Animal trials studies reveal that introducing single dose of Iron Oxide-vitamin nano-composites containing 8.6 mg elemental iron per kg rat body weight is sufficient to correct the hemoglobin level and cure Anemia via oral administration. | 01-28-2016 |
20160050962 | Preconception/Prenatal/Postnatal Optimal Nutrition System, Compositions and Kits for Use Therein, and Methods of Making and Using Same - A nutrition system for use during a preconception period, during pregnancy, during lactation, and/or during postnatal weight loss is disclosed herein. Also disclosed are compositions and kits for use therein, as well as methods of making and using same. Also disclosed are a range of preconception, prenatal, pregnancy, postnatal, and/or lactation food and/or beverage products, assemblies containing same, and methods of production and use thereof. | 02-25-2016 |
20160082061 | NUTRITIONAL COMPOSITION AND METHOD OF MANUFACTURE - A nutritional composition, and method of making it, that includes a carbohydrate, an insulin potentiator, an amino acid, a muscle growth stimulator, an energy increaser, at least one natural supplement for weight loss, reduction of cholesterol levels, and/or increased resistance to stress, and at least one flavoring ingredient. The composition may be provided in dry form for addition to a fluid or in liquid forms. The composition is ingested to improve endurance and muscle tissue repair after exercise. In an embodiment the composition includes vanadyl sulfate, gamma oryzanol, American ginseng, sucralose, and rhodiola rosea. In another embodiment the composition includes vanadyl sulfate, gamma oryzanol, stevia, garcinia cambogia, and diarginine malate. | 03-24-2016 |
20160143891 | COMPOSITIONS AND METHODS FOR TREATING ANEMIA - Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia associated with or resulting from chemotherapy, or anemia associated with AIDS. | 05-26-2016 |
20160158237 | Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates - The present invention provides methods and compositions for treating thyroid-related medical conditions. Many thyroid-related medical conditions exist that go undiagnosed and untreated. These conditions may be prevented and treated with reduced folates and vitamin B12. Administration of reduced folates and vitamin B12 will prevent or treat cerebrospinal folate deficiency, which is linked to thyroid-related medical conditions. Administration of reduced folates and vitamin B12 will also prevent or treat conditions associated with masked megaloblastic anemia and hypothyroidism, and other conditions brought upon through improper thyroid function. Additionally, it is commonplace to treat many thyroid conditions with anti-thyroid drugs or thyroid stimulating drugs. This practice alone is also responsible for causing, or not beneficially addressing, adverse conditions that can be prevented or treated through the methods and compositions discussed herein. | 06-09-2016 |
20160158257 | DIETARY SUPPLEMENT CONTAINING PHOSPHOLIPID-DHA DERIVED FROM EGGS - Described herein are manufactured dietary supplements that contain a phospholipid extract, folic acid, vitamin D, vitamin B | 06-09-2016 |
20160159653 | HIGH ANISOTROPY NANOPARTICLES - New nanoparticles are provided which may have blocking temperatures exceeding 570 K even for particles as small as 8 nm in size. First principles theoretical investigations show that the new behavior is rooted in the giant magnetocrystalline anisotropies due to controlled mixing between carbon p-states and cobalt d-states. Furthermore, assemblies of the new nanoparticles may provide rare earth free permanent magnets having magnetic properties which rival those of rare earth permanent magnets. | 06-09-2016 |
20160193164 | CALCIUM FORMATE AS A SUPPLEMENT TO PREVENT NEURAL TUBE DEFECTS | 07-07-2016 |